-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
-
Summary
-
InMed Pharmaceuticals Inc. quarterly/annual General and Administrative Expense history and growth rate from Q3 2019 to Q2 2025.
- InMed Pharmaceuticals Inc. General and Administrative Expense for the quarter ending June 30, 2025 was $2.25M, a 27.9% increase year-over-year.
- InMed Pharmaceuticals Inc. General and Administrative Expense for the twelve months ending June 30, 2025 was $6.56M, a 13.1% increase year-over-year.
- InMed Pharmaceuticals Inc. annual General and Administrative Expense for 2025 was $6.56M, a 13.1% increase from 2024.
- InMed Pharmaceuticals Inc. annual General and Administrative Expense for 2024 was $5.8M, a 0.84% decline from 2023.
- InMed Pharmaceuticals Inc. annual General and Administrative Expense for 2023 was $5.85M, a 14.8% decline from 2022.
General and Administrative Expense, Trailing 12 Months (USD)
General and Administrative Expense, Quarterly (USD)
General and Administrative Expense, YoY Quarterly Growth (%)